Li; Shoufeng

Patent Applications and Registrations

Patent applications and USPTO patent grants for Li; Shoufeng.The latest application filed is for "lacosamide pharmaceutical composition and dosage form thereof".

Company Profile

2.14.32

Li; Shoufeng - Basking Ridge NJ
LI; Shoufeng - North Brunswick NJ
Li; Shoufeng - Xiamen N/A CN
Li; Shoufeng - Bridgewater NJ
Li; Shoufeng - Xiamen City CN
Li; Shoufeng - Oklahoma City OK
Li; Shoufeng - East Hanover NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Lacosamide Pharmaceutical Composition And Dosage Form Thereof App 20220280456 - Lyu; Shaoqiong ; et al.	2022-09-08
Lacosamide pharmaceutical composition and dosage form thereof Grant 11,337,943 - Lyu , et al. May 24, 2	2022-05-24
Powder for oral suspension containing lamotrigine App 20210401748 - Lu; Enxian ; et al.	2021-12-30
Lacosamide Pharmaceutical Composition And Dosage Form Thereof App 20210283076 - Lyu; Shaoqiong ; et al.	2021-09-16
Powder for oral suspension containing lamotrigine Grant 10,653,626 - Lu , et al.	2020-05-19
Novel Tebipenem Pivoxil Immediate And Modified Release Oral Dosage Forms App 20200016126 - JAIN; Akash ; et al.	2020-01-16
Sustained Release Pharmaceutical Dosage Form of Entecavir App 20190240143 - Lu; Enxian ; et al.	2019-08-08
Powder For Oral Suspension Containing Lamotrigine App 20190060237 - Lu; Enxian ; et al.	2019-02-28
Pharmaceutical composition Grant 9,622,975 - Azria , et al. April 18, 2	2017-04-18
Immediate release 4-methyl-3-4[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imid- azol-1-YL)-3-(trifluoromethyl)phenyl] benzamide formulation Grant 9,301,957 - Bhardwaj , et al. April 5, 2	2016-04-05
IMMEDIATE RELEASE 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imida- zol-1-yl)-3-(trifluoromethyl)phenyl] benzamide FORMULATION App 20150320749 - Bhardwaj; Upkar ; et al.	2015-11-12
Modified Release Of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-[5-(4-methyl-1h-imida- Zol-1-yl)-3-(triflouoromethyl)phenyl] Benzamide Solubilized Using Organic Acids App 20150273070 - Li; Shoufeng ; et al.	2015-10-01
Pharmaceutical Composition App 20150250729 - Azria; Moise ; et al.	2015-09-10
Use Of Calcitonin In Osteoarthritis App 20140271735 - Azria; Moise ; et al.	2014-09-18
Spring loaded docking mechanism Grant 8,800,075 - van Leyen , et al. August 12, 2	2014-08-12
Use of calcitonin in osteoarthritis Grant 8,765,675 - Azria , et al. July 1, 2	2014-07-01
Method for treating bone related diseases and calcium disorders Grant 8,748,383 - Li , et al. June 10, 2	2014-06-10
Pharmaceutical Compositions App 20130245061 - Cao; Yu ; et al.	2013-09-19
Orally Dosed Pharmaceutical Compositions Comprising a Delivery Agent in Micronized Form App 20130230593 - Li; Shoufeng ; et al.	2013-09-05
Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form Grant 8,435,946 - Li , et al. May 7, 2	2013-05-07
Spring Loaded Docking Mechanism App 20130037626 - van Leyen; Jan Christopher ; et al.	2013-02-14
Oral Formulations App 20120093939 - Payne; Adam ; et al.	2012-04-19
Galenical Formulations of a Fixed Dose Combination of Valsartan and Aliskiren App 20120009257 - Ghosh; Indrajit ; et al.	2012-01-12
Pharmaceutical Composition Comprising Aliskiren App 20120003308 - Bose; Sonali ; et al.	2012-01-05
Pharmaceutical Composition App 20110218148 - Azria; Moise ; et al.	2011-09-08
Melt Granulation Process App 20110092515 - Qiu; Zhihui ; et al.	2011-04-21
Use Of Calcitonin In Osteoarthritis App 20100278881 - AZRIA; Moise ; et al.	2010-11-04
Pharmaceutical Combination Of Aliskiren And Valsartan App 20100247645 - Curdy; Catherine ; et al.	2010-09-30
Galenical Formulations Of Organic Compounds App 20100209480 - Altenburger; Ralf ; et al.	2010-08-19
Use of calcitonin in osteoarthritis Grant 7,749,954 - Azria , et al. July 6, 2	2010-07-06
Modified release famciclovir pharmaceutical compositions App 20090023754 - Lee; Wai Yip ; et al.	2009-01-22
Pharmaceutical Composition App 20080255048 - Azria; Moise ; et al.	2008-10-16
Orally Dosed Pharmaceutical Compositions Comprising A Delivery Agent In Micronized Form App 20080234179 - Li; Shoufeng ; et al.	2008-09-25
Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form App 20070065505 - Li; Shoufeng ; et al.	2007-03-22
Use of calcitonin in osteoarthritis App 20060194722 - Azria; Moise ; et al.	2006-08-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.